Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

Autor: Cihan Uras, Neslihan Cabioglu, Fatma Tokat, Ozlem Er, Halil Kara, Taner Korkmaz, Nuran Bese, Umit Ince

Publikováno v: BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)

Abstract Background Recent studies have shown a lower likelihood of locoregional recurrences in patients with a low 21-gene recurrence score (RS). In this single-institution study, we investigated whether there are any associations between different

Externí odkaz: https://doaj.org/article/92f7149da3064caa9a1b866aeaf705c5

Results of Locoregional Radiotherapy or Axillary Dissection in Early Breast Cancer with pN0(is +) and pN1mi Nodal Disease

Autor: Ayse Altinok, Fatma Tokat, Umit Ince, Cihan Uras, Nuran Bese

Publikováno v: Indian Journal of Surgery. 84:697-702

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::48543cc8f08fede32965627b33ce72fd
https://doi.org/10.1007/s12262-021-03179-1

A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer

Autor: Livia Marrazzo, Gustavo Nader Marta, Pierfrancesco Franco, Icro Meattini, Alan Nichol, Dori Benjamin, Liesbeth J. Boersma, Anna M. Kirby, Dirk De Ruysscher, Alice Y. Ho, Jean Philippe Pignol, Charlotte E. Coles, Birgitte Vrou Offersen, Henrik Nissen, Hannah Dahn, Philip Poortmans, S. Hol, Meena S. Moran, Reshma Jagsi, Yvonne Zissiadis, Vratislav Strnad, Cynthia Aristei, Nuran Bese, Orit Kaidar-Person, Yazid Belkacemi

Publikováno v: Kaidar-Person, O, Dahn, H M, Nichol, A M, Boersma, L J, de Ruysscher, D, Meattini, I, Pignol, J P, Aristei, C, Belkacemi, Y, Benjamin, D, Bese, N, Coles, C E, Franco, P, Ho, A Y, Hol, S, Jagsi, R, Kirby, A M, Marrazzo, L, Marta, G N, Moran, M S, Nissen, H D, Strnad, V, Zissiadis, Y, Poortmans, P M & Offersen, B V 2021, ' A Delphi study and International Consensus Recommendations : The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer ', Radiotherapy and Oncology, vol. 164, pp. 115-121 . https://doi.org/10.1016/j.radonc.2021.09.012
Radiotherapy and oncology
Radiotherapy and Oncology, 164, 115-121. Elsevier Ireland Ltd

Bolus serves as a tissue equivalent material that shifts the 95-100% isodose line towards the skin and subcutaneous tissue. The need for bolus for all breast cancer patients planned for postmastectomy radiation therapy (PMRT) has been questioned. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9442f2e726120365a772010ad7f43585
https://pubmed.ncbi.nlm.nih.gov/34563607

Temporary Implant Irradiation: Survey of Turkish Society of Radiation Oncology Breast Cancer Study Group

Autor: Nuran Bese, Nuri Kaydıhan, Gül Alço, Mustafa Şenocak

Publikováno v: Eur J Breast Health

Objective: To understand the clinical approach of radiation oncologists during the treatment of patients with breast reconstruction. Materials and Methods: A questionnaire survey was emailed to 105 active members of the Turkish Radiation Oncology Soc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd7e48760d2b4f8f3e1cf5ce978bf29
https://hdl.handle.net/11443/2045

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor–Positive Breast Cancer

Autor: Jessica St. Louis, Sahsuvar Gokgoz, Paul E. Goss, Nuran Bese, Henry L. Gomez, Pedro Er Liedke, Nora Horick, Gustavo Werutsky, Piiha Lotta Jerevall, Karina J. Matissek, Leif W. Ellisen, Allison MacLeay, Dianne M. Finkelstein, Dennis C. Sgroi, Tanja Badovinac-Crnjevic, Ismet Tasdelen, Kristofer Patel, Zongli Zheng, Jesse Lee, Srinivas Vinod Saladi, Elif Demirdogen, A. John Iafrate, Unal Egeli, Maristela L. Onozato, Carlos H. Barrios, Mehrad Tavallai, Arlene Chan, Long P. Le, Aditya Bardia, Sheng Sun, Yanin Chavarri-Guerra, Sahsine Tolunay, Andrew Schultz, Marcio Debiasi

Publikováno v: Cancer Discovery. 8:336-353

We sought to uncover genetic drivers of hormone receptor–positive (HR+) breast cancer, using a targeted next-generation sequencing approach for detecting expressed gene rearrangements without prior knowledge of the fusion partners. We identified in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::23c87202850f24641439671f808d9db2
https://doi.org/10.1158/2159-8290.cd-17-0535